Exploring Packaging, Storage, and Disposal Solutions to Enhance Opioid Safety
In support of the U.S Food and Drug Administration’s (FDA’s) efforts to reduce the growing epidemic of opioid abuse, dependence, and overdose in the United States, FDA’s “Packaging: Abuse-Deterrent Strategies (PADS)” Task Force is currently exploring whether innovative packaging, storage, and disposal solutions could enhance opioid safety by preventing or deterring misuse, abuse, or inappropriate access to prescription opioids. Identifying key intervention points during opioid use is critical to developing such solutions.
On June 1st, the Duke-Margolis Center for Health Policy hosted a private workshop in support of these efforts. The workshop was convened to examine data needs and guiding design principles for developing packaging, storage, and disposal solutions that have the potential to enhance opioid safety and deter misuse and abuse. Key issues to be addressed in the workshop include:
- The potential role of packaging, storage, and disposal solutions in addressing factors that enable prescription opioid abuse and misuse or inappropriate access
- The current landscape of existing packaging, storage, and disposal solutions that may prevent or deter abuse and misuse or inappropriate access of prescription opioids
- Approaches to evaluating the impact of packaging, storage, and disposal solutions to deter misuse and abuse or inappropriate access of prescription opioids
- Considerations for integrating the use of opioid safety-enhancing packaging, storage, or disposal solutions into healthcare and pharmacy systems
While this project is supported through a cooperative agreement with FDA, the views expressed in the accompanying documents are those of the participants in attendance, and do not necessarily reflect the official positions and policies of the Department of Health and Human Services, or imply endorsements by the U.S. Government or other organizations.